idiopathic pulmonary fibrosis

Serum KL-6 as a biomarker for interstitial lung diseases in a clinical setting: application of a fully automated immunoassay
Francesco Bonella, Balasz Hegedues, Sandra Langer, Fanny Honshoven, Eva Gottstein, Dirk Theegarten, Ulrich Costabel

European Respiratory Journal Sep 2019, 54 (suppl 63) PA4697; DOI: 10.1183/13993003.congress-2019.PA4697
Change in serum surfactant protein (SP)-A, SP-D and KL-6 predict the therapeutic effect of antifibrotic drugs in IPF
Takumi Yoshikawa, Mitsuo Otsuka, Kimiyuki Ikeda, Yuki Mori, Yasuaki Umeda, Hirotaka Nishikiori, Satsuki Miyajima, Mamoru Takahashi, Koji Kuronuma, Hirofumi Chiba, Hiroki Takahashi

European Respiratory Journal Sep 2019, 54 (suppl 63) PA4704; DOI: 10.1183/13993003.congress-2019.PA4704
Evaluation of CD163 expression on alveolar macrophages from BAL of patients with Fibrotic Lung Diseases
Eirini Vasarmidi, Eleni Bibaki, Chara Koutoulaki, Semeli Mastrodemou, Athina Trachalaki, Nikos Tzanakis, Eliza Tsitoura, Katerina Antoniou

European Respiratory Journal Sep 2019, 54 (suppl 63) PA4694; DOI: 10.1183/13993003.congress-2019.PA4694
A registry of patients with idiopathic pulmonary fibrosis in Russia: 2-yr results and therapeutic modalities in real-life practice
Svetlana Yu. Chikina, Sergey Avdeev, Andrey Belevsky, Alexander Cherniak, Natalia Kravchenko

European Respiratory Journal Sep 2019, 54 (suppl 63) PA4711; DOI: 10.1183/13993003.congress-2019.PA4711
The Latin American Idiopathic Pulmonary Fibrosis Registry (REFIPI): Baseline Characteristics
Ivette Buendia Roldán, Fabian Caro, Pablo Curbelo, Ronaldo Kairalla, Mayra Mejia, Lorena Noriega, Francisco Paulin, Alvaro Undurraga, Moises Selman, On Behalf Refipi Group

European Respiratory Journal Sep 2019, 54 (suppl 63) PA4699; DOI: 10.1183/13993003.congress-2019.PA4699
Real-life experience of familial fibrosis in a Belgian university
Anne-sophie Petit, Caroline Dahlqvist, Anne De Leener, Caroline Kannengiesser, Raphaël Borie, Antoine Froidure

European Respiratory Journal Sep 2019, 54 (suppl 63) PA4709; DOI: 10.1183/13993003.congress-2019.PA4709
Best tolerated dose of Pirfenidone in patients with idiopathic pulmonary fibrosis
Neha Agrawal, Preyas J Vaidya, Vinod B Chavhan, Tejashree T Lele, Anne Leuppi-Taegtmeyer, Joerg D Leuppi, Prashant N Chhajed

European Respiratory Journal Sep 2019, 54 (suppl 63) PA4707; DOI: 10.1183/13993003.congress-2019.PA4707
Normoxemic patients at rest with Interstitial Lung Disease and desaturation in the 6MWT
David Jorge Araújo Barros Coelho, Mafalda Vanzeller, Patricia Caetano Mota, Marta Drummond

European Respiratory Journal Sep 2019, 54 (suppl 63) PA4135; DOI: 10.1183/13993003.congress-2019.PA4135
A new treatment algorithm for acute exacerbation of IPF: a retrospective cohort study
Andrea Vianello, Silvia Ferrarese, Beatrice Molena, Giovanna Arcaro, Fausto Braccioni, Luciana Paladini, Federico Gallan

European Respiratory Journal Sep 2019, 54 (suppl 63) PA4018; DOI: 10.1183/13993003.congress-2019.PA4018
Late Breaking Abstract - WNT/ß-catenin signaling induces cellular senescence in lung alveolar epithelial cells
Mareike Lehmann, Kathrin Mutze, Qiangjiang Hu, Melanie Königshoff

European Respiratory Journal Sep 2019, 54 (suppl 63) PA4122; DOI: 10.1183/13993003.congress-2019.PA4122

Main menu

User menu

Search

idiopathic pulmonary fibrosis

Pages

Contact us